Danaher Corporation (BIT:1DHR)

Market Cap	113.19B
Revenue (ttm)	20.50B
Net Income (ttm)	2.91B
Shares Out	n/a
EPS (ttm)	4.02
PE Ratio	38.86
Forward PE	22.50
Dividend	0.81 (0.49%)
Ex-Dividend Date	Sep 25, 2025

Volume	n/a
Average Volume	11
Open	166.48
Previous Close	166.48
Day's Range	166.48 - 166.48
52-Week Range	156.48 - 251.96
Beta	n/a
RSI	30.55
Earnings Date	Oct 21, 2025

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. It operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment provides bioprocessing technologies, consumables, services, and solutions that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for man...

• Industry: Laboratory Analytical Instruments
• Founded: 1969
• Employees: 63,000
• Stock Exchange: Borsa Italiana
• Ticker Symbol: 1DHR

Financial Performance

In 2024, Danaher's revenue was $23.88 billion, a decrease of -0.06% compared to the previous year's $23.89 billion. Earnings were $3.90 billion, a decrease of -17.79%.

Financial numbers in USD